1494 studies found for:    Multiple Sclerosis
Show Display Options
Rank Status Study
21 Active, not recruiting A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart™ Device
Conditions: Multiple Sclerosis;   Relapsing-Remitting
Interventions: Other: Technical support for the RebiSmart™ device;   Other: Patient support program (MinSupport Plus)
22 Active, not recruiting Improving Hand Use in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Behavioral: CI Therapy;   Behavioral: CAM treatments
23 Recruiting A Telemedicine Mindfulness-based Intervention for People With Multiple Sclerosis and Their Caregivers
Condition: Multiple Sclerosis
Interventions: Behavioral: Telemedicine mindfulness-based intervention;   Behavioral: Psycho-education intervention
24 Completed Transcranial Doppler in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Device: TCD baseline;   Device: TCD after bosentan administration;   Device: NIRS baseline;   Device: NIRS after bosentan administration
25 Terminated Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist
Condition: Multiple Sclerosis
Intervention:
26 Completed Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
Conditions: Multiple Sclerosis;   Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Interferon-1beta (Betaseron, BAY86-5046)
27 Completed
Has Results
Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis Patients
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Dietary Supplement: Vitamin A;   Drug: Placebo
28 Recruiting A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis
Conditions: Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Clinically Isolated Syndrome
Intervention:
29 Completed An Observational Study to Assess the Quality of Life of the Patients With Multiple Sclerosis and Their Caregivers
Condition: Multiple Sclerosis
Intervention:
30 Completed Auditory Function in Patients With and Without Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Hearing in Multiple Sclerosis
31 Unknown  Combination Therapy of Betaseron-Prograf in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Interferon beta-1b and Tacrolimus
32 Completed Responsiveness and Minimal Clinical Important Difference of the Multiple Sclerosis Questionnaire for Physiotherapists
Condition: Multiple Sclerosis
Intervention: Other: Questionnaires, EDSS, physical test
33 Recruiting Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis;   Multiple Sclerosis, Relapsing-Remitting;   Multiple Sclerosis, Chronic Progressive
Intervention: Other: Brain MRI
34 Completed Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
Conditions: Multiple Sclerosis;   Optic Neuritis;   Transverse Myelitis;   Acute Brainstem/Cerebellar Syndrome
Intervention: Drug: interferon beta 1a 30 ug IM once weekly
35 Completed
Has Results
Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod;   Drug: Placebo
36 Completed
Has Results
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: Alemtuzumab;   Biological: Interferon beta-1a
37 Completed
Has Results
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: Alemtuzumab 12 mg;   Biological: Alemtuzumab 24 mg;   Biological: Interferon beta-1a
38 Recruiting Evaluation of Coagulation in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
39 Completed Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: intravenous injection of mesenchymal stem cells;   Biological: injection of cell free media
40 Completed
Has Results
Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Interferon beta 1-a;   Drug: glatiramer acetate;   Other: placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years